Research ExplorerScientific StaffDavid Evans Publications

Dr.phil. ID: 72566

David Evans

graph of relations
Affiliations
1 - 14 out of 14Page size: 50

Publications

  1. 2009

  2. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

    Edmondson, A. C., Brown, R. J., Kathiresan, S., Cupples, L. A., Demissie, S., Manning, A. K., Jensen, M. K., Rimm, E. B., Wang, J., Rodrigues, A., Bamba, V., Khetarpal, S. A., Wolfe, M. L., Derohannessian, S., Li, M., Reilly, M. P., Aberle, J., Evans, D., Hegele, R. A. & Rader, D. J., 2009, In: J CLIN INVEST. 119, 4, p. 1042-1050 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2007

  4. The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.

    Evans, D. & Beil, F. U., 2007, In: BMC MED GENET. 8, p. 56

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2006

  6. The E670G SNP in the PCSK9 gene is associated with polygenic hypercholesterolemia in men but not in women.

    Evans, D. & Beil, F. U., 2006, In: BMC MED GENET. 7, p. 66

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2005

  8. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet.

    Aberle, J., Evans, D., Beil, F. U. & Seedorf, U., 2005, In: CLIN GENET. 68, 2, p. 152-154 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.

    Evans, D., Seedorf, U. & Beil, F. U., 2005, In: CLIN GENET. 68, 4, p. 369-372 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2003

  11. The association of the R219K polymorphism in the ATP-binding cassette transporter 1 ( ABCA1) gene with coronary heart disease and hyperlipidaemia.

    Evans, D. & Beil, F. U., 2003, In: J MOL MED. 81, 4, p. 264-270 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.

    Evans, D., Buchwald, A. & Beil, F. U., 2003, In: J MOL MED. 81, 10, p. 645-654 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2001

  14. A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus.

    Evans, D., Aberle, J., Wendt, D., Wolf, A., Beisiegel, U. & Mann, W. A., 2001, In: J MOL MED. 79, 4, p. 198-204 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Association between polymorphisms in candidate genes and morbid obesity.

    Evans, D., Wolf, A. M., Nellessen, U., Ahle, S., Kortner, B., Kuhlmann, H. W. & Beisiegel, U., 2001, In: INT J OBESITY. 25, 1, p. 19-21 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.

    Evans, D., de Heer, J., Hagemann, C., Wendt, D., Wolf, A., Beisiegel, U. & Mann, W. A., 2001, In: EXP CLIN ENDOCR DIAB. 109, 3, p. 151-154 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2000

  18. Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans.

    Evans, D., Minouchehr, S., Hagemann, G., Mann, W. A., Wendt, D., Wolf, A. & Beisiegel, U., 2000, In: INT J OBESITY. 24, 10, p. 1239-1245 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity.

    Evans, D., Mann, W. A., de Heer, J., Michel, U., Wendt, D., Kortner, B., Wolf, A. & Beisiegel, U., 2000, In: INT J OBESITY. 24, 5, p. 647-651 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. 1998

  21. Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.

    Evans, D., Wendt, D., Ahle, S., Guerra, A. & Beisiegel, U., 1998, In: HUM MUTAT. 12, 3, p. 217 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.

    Brümmer, D., Evans, D., Berg, D., Greten, H., Beisiegel, U. & Mann, W. A., 1998, In: J MOL MED. 76, 5, p. 355-364 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review